1. Inicio
  2. Publicaciones
  3. Penetrance of Dilated Cardiomyopathy in Genotype-Positive Relatives

Penetrance of Dilated Cardiomyopathy in Genotype-Positive Relatives

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Cabrera-Romero, E
  • Ochoa, JP
  • Barriales-Villa, R
  • Bermúdez-Jiménez, FJ
  • Climent-Payá, V
  • Zorio, E
  • Espinosa, MA
  • Gallego-Delgado, M
  • Navarro-Peñalver, M
  • Arana-Achaga, X
  • Piqueras-Flores, J
  • Espejo-Bares, V
  • Rodríguez-Palomares, JF
  • Lacuey-Lecumberri, G
  • López, J
  • Tiron, C
  • Peña-Peña, ML
  • García-Pinilla, JM
  • Lorca, R
  • Ripoll-Vera, T
  • Díez-López, C
  • Mogollon, MV
  • García-Alvarez, A
  • Brion, M
  • Larrañaga-Moreira, JM
  • Jiménez-Jáimez, J
  • García-Alvarez, MI
  • Vilches, S
  • Villacorta, E
  • Sabater-Molina, M
  • Solla-Ruiz, I
  • Royuela, A
  • Domínguez, F
  • Mirelis, JG
  • Garcia-Pavia, P

Grupos

Abstract

BACKGROUND Disease penetrance in genotype -positive (G+) relatives of families with dilated cardiomyopathy (DCM) and the characteristics associated with DCM onset in these individuals are unknown. OBJECTIVES This study sought to determine the penetrance of new DCM diagnosis in G+ relatives and to identify factors associated with DCM development. METHODS The authors evaluated 779 G+ patients (age 35.8 +/- 17.3 years; 459 [59%] females; 367 [47%] with variants in TTN ) without DCM followed at 25 Spanish centers. RESULTS After a median follow-up of 37.1 months (Q1 -Q3: 16.3-63.8 months), 85 individuals (10.9%) developed DCM (incidence rate of 2.9 per 100 person -years; 95% CI: 2.3-3.5 per 100 person -years). DCM penetrance and age at DCM onset was different according to underlying gene group (log -rank P = 0.015 and P <0.01, respectively). In a multivariable model excluding CMR parameters, independent predictors of DCM development were: older age (HR per 1 -year increase: 1.02; 95% CI: 1.0-1.04), an abnormal electrocardiogram (HR: 2.13; 95% CI: 1.38-3.29); presence of variants in motor sarcomeric genes (HR: 1.92; 95% CI: 1.05-3.50); lower left ventricular ejection fraction (HR per 1% increase: 0.86; 95% CI: 0.82-0.90) and larger left ventricular end -diastolic diameter (HR per 1 -mm increase: 1.10; 95% CI: 1.06-1.13). Multivariable analysis in individuals with cardiac magnetic resonance and late gadolinium enhancement assessment (n = 360, 45%) identi fied late gadolinium enhancement as an additional independent predictor of DCM development (HR: 2.52; 95% CI: 1.43-4.45). CONCLUSIONS Following a first negative screening, approximately 11% of G+ relatives developed DCM during a median follow-up of 3 years. Older age, an abnormal electrocardiogram, lower left ventricular ejection fraction, increased left ventricular end -diastolic diameter, motor sarcomeric genetic variants, and late gadolinium enhancement are associated with a higher risk of developing DCM. (J Am Coll Cardiol 2024;83:1640 -1651) (c) 2024 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY -NC -ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Datos de la publicación

ISSN/ISSNe:
0735-1097, 1558-3597

JACC-Journal of the American College of Cardiology  ELSEVIER SCIENCE INC

Tipo:
Article
Páginas:
1640-1651
PubMed:
38658103
Factor de Impacto:
9,756 SCImago ℠
Cuartil:
Q1 SCImago ℠

Citas Recibidas en Web of Science: 16

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • dilated cardiomyopathy; genetics; late gadolinium enhancement; penetrance

Campos de Estudio

Cita

Compartir